Literature DB >> 32644100

Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer.

Tal Hadar1, Pnina Mor2,3, Gefen Amit4, Sari Lieberman3, David Gekhtman5, Rachel Rabinovitch6, Ephrat Levy-Lahad3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32644100      PMCID： PMC7349080          DOI： 10.1001/jamaoncol.2020.2059

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Broadening Criteria for BRCA1/2 Evaluation: Placing the USPSTF Recommendation in Context.

Authors:  Susan Domchek; Mark Robson
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

2.  NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

Authors:  Mary B Daly; Robert Pilarski; Matthew B Yurgelun; Michael P Berry; Saundra S Buys; Patricia Dickson; Susan M Domchek; Ahmed Elkhanany; Susan Friedman; Judy E Garber; Michael Goggins; Mollie L Hutton; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison W Kurian; Christine Laronga; Jennifer K Litton; Julie S Mak; Carolyn S Menendez; Sofia D Merajver; Barbara S Norquist; Kenneth Offit; Tuya Pal; Holly J Pederson; Gwen Reiser; Kristen Mahoney Shannon; Kala Visvanathan; Jeffrey N Weitzel; Myra J Wick; Kari B Wisinski; Mary A Dwyer; Susan D Darlow
Journal:  J Natl Compr Canc Netw       Date:  2020-04       Impact factor: 11.908

3.  Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.

Authors:  Efrat Gabai-Kapara; Amnon Lahad; Bella Kaufman; Eitan Friedman; Shlomo Segev; Paul Renbaum; Rachel Beeri; Moran Gal; Julia Grinshpun-Cohen; Karen Djemal; Jessica B Mandell; Ming K Lee; Uziel Beller; Raphael Catane; Mary-Claire King; Ephrat Levy-Lahad
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-05       Impact factor: 11.205

4.  Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.

Authors:  Bernadette A M Heemskerk-Gerritsen; Agnes Jager; Linetta B Koppert; A Inge-Marie Obdeijn; Margriet Collée; Hanne E J Meijers-Heijboer; Denise J Jenner; Hester S A Oldenburg; Klaartje van Engelen; Jakob de Vries; Christi J van Asperen; Peter Devilee; Marinus J Blok; C Marleen Kets; Margreet G E M Ausems; Caroline Seynaeve; Matti A Rookus; Maartje J Hooning
Journal:  Breast Cancer Res Treat       Date:  2019-07-13       Impact factor: 4.872

5.  International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.

Authors:  Kelly Metcalfe; Andrea Eisen; Leigha Senter; Susan Armel; Louise Bordeleau; Wendy S Meschino; Tuya Pal; Henry T Lynch; Nadine M Tung; Ava Kwong; Peter Ainsworth; Beth Karlan; Pal Moller; Charis Eng; Jeffrey N Weitzel; Ping Sun; Jan Lubinski; Steven A Narod
Journal:  Br J Cancer       Date:  2019-04-11       Impact factor: 7.640

Review 6.  Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers.

Authors:  Claudia Marchetti; Francesca De Felice; Innocenza Palaia; Giorgia Perniola; Angela Musella; Daniela Musio; Ludovico Muzii; Vincenzo Tombolini; Pierluigi Benedetti Panici
Journal:  BMC Womens Health       Date:  2014-12-12       Impact factor: 2.809
  6 in total
  3 in total

1.  Prevalent versus incident breast cancers: benefits of clinical and radiological monitoring in women with pathogenic BRCA1/2 variants.

Authors:  Claire Saule; Solveig Menu-Hespel; Matthieu Carton; Caroline Malhaire; Pascal Cherel; Fabien Reyal; Marine Le Mentec; Eugénie Guillot; Anne Donnadieu; Nasrine Callet; Sophie Frank; Florence Coussy; Dominique Stoppa-Lyonnet; Emmanuelle Mouret-Fourme
Journal:  Eur J Hum Genet       Date:  2022-02-25       Impact factor: 5.351

2.  "High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis".

Authors:  Shay Shraga; Albert Grinshpun; Aviad Zick; Luna Kadouri; Yogev Cohen; Ofra Maimon; Yael Adler-Levy; Galina Zeltzer; Avital Granit; Bella Maly; Einat Carmon; Vardiella Meiner; Tamar Sella; Tamar Hamburger; Tamar Peretz
Journal:  Front Oncol       Date:  2021-09-02       Impact factor: 6.244

Review 3.  Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2.

Authors:  Rinat Bernstein-Molho; Eitan Friedman; Ella Evron
Journal:  Cancers (Basel)       Date:  2022-09-22       Impact factor: 6.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.